ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1654	National Cancer Institute	Html	en	Gerson Therapy (PDQ®)–Health Professional Version	Expert-reviewed information summary about Gerson therapy as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	complex regimen 0.484073 prescribed conventional regimen 0.48627 body 0.480118 treatment regimen 0.476762 New York City 0.503592 American Cancer Society 0.4659 normal metabolic state 0.454242 Gerson’s data 0.572285 coffee enemas 0.55048 Gerson Research Organization 0.580725 cancer information summary 0.482421 cancer therapies 0.454018 colorectal cancer 0.455812 diet regimen 0.532413 Gerson therapy 0.918805 patients 0.555703 cancer patients 0.512802 Gerson’s life 0.570445 Gerson regimen 0.719238 flaxseed oil 0.455436 diet group 0.469079 Charlotte Gerson Straus 0.587654 injectable crude liver 0.462964 gonzalez regimen 0.487953 potassium 0.46778	United States 0.4578 Gerson approach 0.560315 cancer cells 0.467412 5-year survival rate 0.480223 cancer cell biology 0.469353 Gerson regimen. 0.568736 A. Pancreatic enzymes 0.456434 potassium solution 0.46218 excess sodium 0.454821 Gerson Hospital 0.567697 Gerson approach. 0.560098 National Cancer Institute 0.466567 Desiccated liver capsules 0.461935 stage I–II patients 0.465698 New York 0.508367 Gerson segment 0.563678 pancreatic enzymes 0.529579 Gerson Institute 0.579619 healthy liver function. 0.462886 Gerson diet 0.622931 crude liver extract 0.544679 melanoma patients 0.45525 cancer 0.570183 Max Gerson 0.650691	CLICK HERE
1691	National Cancer Institute	Html	en	Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®)–Health Professional Version	Calcium, green tea, lycopene, pomegranate, selenium, soy and vitamin E have been studied for prostate cancer prevention or treatment. Read about laboratory and human studies on various prostate supplements in this expert-reviewed summary.	atypical small acinar 0.591788 dietary lycopene 0.5816 local-stage prostate cancer 0.605358 prostate cancer cell 0.611618 prostate cancer survivors 0.597981 total prostate cancer 0.586726 occult prostate cancer 0.591218 lycopene serum concentration 0.581941 lycopene intake 0.604495 prostate cancer cells. 0.594787 serum lycopene 0.591044 hormone-refractory prostate cancer 0.585389 metastatic prostate cancer 0.596215 cancer prostate cells 0.587339 prostate cancer incidence 0.586787 prostate cancer cells 0.74273 prostate cancer risk 0.675977 prostate cancer patients 0.695715 serum lycopene concentrations 0.582255 prostate cancer aggressiveness 0.585035 prostate cancer progressi 0.584763 lycopene 0.683385 end-of-study prostate lycopene 0.623399 Prostate Cancer Prevention 0.597202 serum psa levels 0.589012	human prostate cancer 0.61272 plasma lycopene levels 0.594142 study 0.645275 androgen-independent prostate cancer 0.585034 prostate cancer development 0.59941 nonmetastatic prostate cancer 0.584711 -resistant prostate cancer 0.587482 high-grade prostate cancer 0.596056 Prostate CAncer Therapy 0.605352 prostate cancer mortality 0.5969 prostate cancer biomarkers 0.590502 prostate cancer cases 0.586568 prostate lycopene concentration 0.627986 green tea 0.644093 prostate cancer patients. 0.585445 lycopene blood levels 0.586499 prostate cancer 0.954937 prostate cancer. 0.620441 aggressive prostate cancer 0.587452 prostate cancer risk. 0.60813 prostate cancer progression 0.591862 prostate lycopene concentrations 0.629097 lycopene levels 0.595352 small acinar proliferation 0.592927	CLICK HERE
1697	National Cancer Institute	Html	en	High-Dose Vitamin C (PDQ®)–Patient Version	Expert-reviewed information summary about the use of high-dose vitamin C as a treatment for people with cancer.	cancer treatment 0.409014 Vitamin C levels 0.46062 chemotherapy 0.385658 PDQ cancer information 0.495143 Cancer Complementary 0.400016 vitamin C therapy 0.473688 vitamin C. Patients 0.500759 vitamin C. Studies 0.500091 clinical trials 0.625144 cancer information summary 0.452988 laboratory studies 0.446817 alternative cancer therapies 0.39781 clinical trial 0.386901 high doses 0.433559 prostate cancer cells 0.388026 CAM cancer research 0.38618 ovarian cancer 0.395778 malignant mesothelioma 0.387621 High-Dose Vitamin C. 0.544572 patients 0.543391 cancer patients 0.435773 NCI PDQ cancer 0.414799 cancer information database 0.396035 effects 0.387385	Therapies Editorial Board 0.399092 cancer information 0.505736 treatment 0.52957 breast cancer cells 0.389833 intravenous high-dose vitamin 0.577226 Complementary Therapies Editorial 0.414088 Drug Administration 0.422556 Cancer Information Specialist 0.391085 dehydroascorbic acid 0.390795 cancer cells 0.552348 Cancer Information Service 0.451182 anticancer drugs 0.396426 high-dose ascorbic acid 0.545315 National Cancer Institute 0.563244 alternative medicine 0.442263 health care 0.392613 advanced pancreatic cancer 0.416341 high-dose IV vitamin 0.624976 vitamin C treatment 0.515175 breast cancer 0.420605 animal studies 0.461706 alternative therapies 0.414436 high-dose vitamin 0.916436 cancer information summaries 0.396462	CLICK HERE
1752	National Cancer Institute	Html	en	Common Moles, Dysplastic Nevi, and Risk of Melanoma	A fact sheet about moles and how some moles may be related to melanoma, the most serious type of skin cancer. Includes photos of differences between moles and cancer.	skin cancer 0.396204 new pencil eraser 0.340631 new mole 0.324515 people—have common moles 0.296925 areas 0.255107 Cancer Statistics Review 0.258106 skin surface 0.252994 American Cancer Society 0.291862 dysplastic nevi 0.760688 ABCDE features 0.255948 shape 0.300226 normal moles 0.26535 melanoma 0.905882 new moles 0.27436 distinct edge 0.298497 UV radiation 0.254044 mole look 0.348624 early melanoma 0.368768 color changes 0.261127 following changes 0.256625 moderately increased chance 0.26864 dysplastic nevus 0.99874 dark skin 0.328273 skin damage 0.265216	new colored area 0.350978 mole changes 0.343324 skin 0.706105 people—develop melanoma 0.334635 cancer cells 0.262185 sun 0.303017 atypical mole 0.288433 National Cancer Institute 0.258053 frequent skin exam 0.273598 common moles 0.677867 chance 0.337967 greater chance 0.265511 American adults—about 0.256684 surface texture 0.317122 Evolving. The mole 0.285916 people 0.632361 doctor 0.289469 normal skin tone 0.268972 family history 0.256672 early melanoma detection 0.355222 unusual mole 0.314622 common mole 0.732427 common mole look 0.339723 fair skin 0.271925	CLICK HERE
1823	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.	Scandinavian Sarcoma Group 0.539831 Lippincott Williams 0.562481 bEl tumor 0.509518 Compton CC 0.522215 Cancer Institute Surveillance 0.506324 Antonescu CR 0.5084 Sarcoma Group 0.551693 Sin embargo 0.587887 tumor center 0.509169 observación versus 0.507069 largo plazo 0.5106 7th ed 0.522519 DeVita VT Jr 0.615914 from sarcomas 0.514899 Tumores osteocondrales.Condrosarcomas 0.512024 Prognostic factors 0.507702 lymph nodes 0.507203 Rosenberg SA 0.558836 T1b Tumor 0.509623 tumor lipomatoso atípico 0.511636 soft tissue sarcoma 0.94016 Lawrence TS 0.559677 fibroso maligno 0.507755 Cancer Centers Sarcoma 0.522459 localised limb soft 0.508432	sarcoma patients 0.519354 metastasis from soft 0.508028 Tumores vasculares.Hemangioendotelioma 0.512057 O'Sullivan B 0.529169 tratamiento adyuvante versus 0.512692 versus quimioterapia 0.510953 Malawer MM 0.508085 Nielsen T 0.507472 Tumores adipocíticos.Liposarcoma 0.51216 Cancer Staging Manual 0.545483 Maki RG 0.50832 potencial metastásico 0.508732 recidivas locales 0.527298 New York 0.519322 9th ed 0.564335 high risk soft 0.507723 adult soft tissue 0.530167 Byrd DR 0.520996 T2b Tumor 0.50961 mutación genética ptc 0.506056 Helman LJ 0.508415 Sarcoma Group study 0.521636 Molecular biology 0.507762 AJCC Cancer Staging 0.547586	CLICK HERE
1873	National Cancer Institute	Html	es	Tratamiento del sarcoma uterino (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma uterino.	Obstet Gynecol 0.426292 Major FJ 0.422403 sarcomas uterinos 0.471793 cisplatin as 0.411109 Markman M 0.40448 gynecologic cancer 0.405911 prognostic factors 0.405684 Brunetto VL 0.40512 Sin embargo 0.405423 or without paclitaxel 0.411277 fase ii 0.413551 Ifosfamide treatment 0.404047 endometrial stromal sarcoma 0.415162 Radiat Oncol Biol 0.40725 siguientes puntos 0.405418 oncology group study 0.684258 stromal sarcomas previously 0.409618 patología equivocada 0.404764 Barrett RJ 0.404588 Kilgore L 0.404374 recurrent or metastatic 0.405758 mixed mesodermal tumors 0.448955 Gynecologic Oncology Group 0.969258 Gynecol Oncol 0.445429 Filiaci V 0.404525	Beecham J 0.404572 or recurrent leiomyosarcoma 0.405872 Blessing JA 0.5678 meses vs 0.434084 Organización Mundial 0.408363 pilot study 0.40409 sarcomas mesodérmicos mixtos 0.406902 Smith MR 0.405644 as second-line chemotherapy 0.406079 or recurrent 0.412147 New York 0.404218 Peters WA 0.405698 Clin Oncol 0.49692 combination chemotherapy 0.409211 verdaderos sarcomas 0.414072 Oncol Biol Phys 0.407314 cuerpo uterino 0.408492 elementos homólogos 0.406306 estadio iii 0.405213 Rosenshein N 0.4046 stromal sarcoma 0.431127 Homesley HD 0.404643 dimethyl triazenoimidazole carboxamide 0.404595 with or without 0.432244	CLICK HERE
2001	National Cancer Institute	Html	es	Familiares a cargo de pacientes de cáncer: funciones y desafíos (PDQ®)–Versión para profesionales de salud	Sumario informativo revisado por expertos acerca de los desafíos que enfrentan los familiares a cargo de los pacientes con cáncer. Este resumen se centra en las funciones típicas y las inquietudes de las personas a cargo del paciente y en las intervenciones útiles para esas personas.	etapa final 0.435131 Cancer Communication Assessment 0.482566 giving bad news 0.42261 to breast 0.424042 Sin embargo 0.471583 receiving palliative care 0.419812 American Cancer Society 0.47018 Family support 0.41866 family to breast 0.421621 CA Cancer 0.459636 Given BA 0.442227 Communication Assessment Tool 0.434693 Rose JH 0.438883 family meetings 0.426208 Estados Unidos 0.421866 Support Care 0.447919 Caregivers Based 0.422755 Palliat Care 0.44789 patients with 0.44256 Pain Symptom Manage 0.455568 Support Oncol 0.41857 Baile WF 0.422726 Family Caregiver Support 0.426151 family caregivers 0.94013 Crit Care Nurs 0.421936	Oncol Nurs Forum 0.49008 with family caregivers 0.435774 Care Cancer 0.474055 Cancer Facts 0.43863 Arnold RM 0.422137 palliative care 0.565514 Hosp Palliat Care 0.420581 paciente cumpla 0.459325 terminally ill patients 0.428058 Family caregiver quality 0.42241 communication skills 0.434733 cancer pain 0.552042 Crit Care 0.427432 Palliat Med 0.438559 Given CW 0.427811 breast cancer 0.524972 Arch Intern Med 0.454734 Conducting family meetings 0.417671 Baider L 0.421555 caregivers with 0.421979 placing family meetings 0.417694 Crit Care Med 0.422158 symptoms among caregivers 0.425057 cancer communication 0.540368	CLICK HERE
2026	National Cancer Institute	Html	es	Prevención del cáncer colorrectal (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	colorectal adenoma chemoprevention 0.338068 colorectal neoplasia among 0.319011 long-term risk 0.313313 Adults With Colorectal 0.319346 Sin embargo 0.339382 Gastrointest Endosc 0.311269 largo plazo 0.32477 CPS II 0.314437 flexible sigmoidoscopy screening 0.31731 Preventive Services Task 0.332229 colorectal cancer 0.908646 population-based study 0.314294 Estados Unidos 0.331084 Natl Cancer Inst 0.334301 Women's Health Study 0.324602 after colonoscopy 0.309105 CCR multivariantes 0.345859 Aspirin Trial 0.311104 Women's Health Initiative 0.338408 colorectal adenomatous polyps 0.317676 Health Initiative 0.348288 colorrectal hereditario 0.317986 Women's Health 0.346194 cancer prevention 0.326424 Rothwell PM 0.314674	colorectal adenoma 0.357654 Health Study 0.364941 sporadic colorectal adenomas 0.324242 RR multivariante 0.309686 CCR clínico 0.37477 Health Study Research 0.310687 left-sided colorectal neoplasms 0.31858 primary prevention 0.311318 Hereditary Cancer Syndromes 0.314398 Epidemiol Biomarkers Prev 0.320559 arteriopatía coronaria 0.30952 riesgo promedio 0.330242 antecedentes familiares 0.330027 Cancer Prevention Study 0.318847 Intern Med 0.471733 cohort study using 0.309014 Clin Oncol 0.310431 Services Task Force 0.331368 systematic review 0.369209 Giovannucci E 0.31569 physical activity 0.319835 Protection from 0.309663 Women’s Health Initiative 0.324227 with colorectal cancer 0.348991	CLICK HERE
2038	National Cancer Institute	Html	es	Prevención del cáncer de piel (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de piel y sobre las investigaciones dirigidas a prevenir esta enfermedad.	nevo atípico 0.426748 almacena agua 0.428194 voluntarios sanos 0.420911 filtros solares 0.422801 ropa protectora 0.423732 menor exposición 0.423337 protector solar 0.980296 protector solar ayuda 0.457908 siguientes ejemplos 0.47268 luz solar 0.660447 vitamina d 0.429105 National Cancer Institute 0.427791 piel melanoma 0.815892 Instituto Nacional 0.448341	lunares benignos 0.424057 antecedentes familiares 0.421492 lámparas solares 0.426025 suficientes estudios 0.422469 Physician Data Query 0.500422 radiación uv 0.839863 Estados Unidos 0.55931 vitamina b3 0.46569 suficiente ejercicio 0.427407 prevención revisa 0.424823 PDQ Prevención 0.445149 siguientes sustancias 0.424243 radiación ultravioleta 0.557367 siguientes sumarios 0.449523	CLICK HERE
4393	National Cancer Institute	Html	en	Care for Childhood Cancer Survivors	Survivorship care for children who have been treated for cancer is important. Get your child's treatment summary, survivorship plan, and recommendations on follow-up care clinics. Learn about long-term and late effects.	cancer treatment 0.326817 child needs 0.304086 follow-up care plan 0.413114 Planning fact sheet 0.303028 type 0.300894 health care team 0.507646 children 0.315621 follow-up care clinics 0.3448 survivorship clinics 0.2728 increased risk 0.28401 clinical trial 0.299772 survivorship care 0.448293 follow-up care visits 0.396149 child’s recovery 0.291653 Cancer Survivorship Care 0.352592 physical late effects 0.431203 survivorship care plan 0.433534 late side effects 0.29008 family health history 0.303512 health problems 0.288413 cognitive late effects 0.426207 Treatment dates 0.285186 radiation therapy 0.304846 Supportive care 0.276073 new routines 0.26175	long-awaited time 0.26767 late effects 0.939895 child 0.816649 treatment summary 0.334731 treatment information 0.286208 Emotional late effects 0.333335 survivor support groups 0.293019 treatment 0.559585 new phase 0.261152 post-traumatic stress disorder 0.292738 follow-up care plans 0.34673 children’s cancer 0.274057 palliative care 0.276488 Childhood Cancer 0.261784 Late Effects Directory 0.342069 child receive 0.286057 mental health support 0.300564 Survivorship care plans 0.341053 Family-based care 0.275482 child’s ability 0.286297 long-term side effects 0.358965 cancer 0.37733 follow-up care 0.618265 time 0.296976	CLICK HERE